We are live on ! Find out more
PC

Polar Capital Portfolio holdings

AUM $13.5B
1-Year Est. Return 55.9%
This Fund
S&P 500
This Quarter Est. Return
-5.07%
1 Year Est. Return
+55.9%
3 Year Est. Return
+127.44%
5 Year Est. Return
+269.08%
10 Year Est. Return
AUM
$4.94B
AUM Growth
-$256M
Cap. Flow
+$155M
Cap. Flow %
3.13%
Top 10 Hldgs %
23%
Holding
310
New
46
Increased
109
Reduced
88
Closed
39

Top Buys

Rank Stock Value
1
AGN
Allergan plc
AGN
+$52.6M
2
UNH icon
UnitedHealth
UNH
+$48.5M
3
LLY icon
Eli Lilly
LLY
+$40.2M
4
BAC icon
Bank of America
BAC
+$33.6M
5
PFE icon
Pfizer
PFE
+$32.9M

Sector Composition

Rank Sector Weight
1 Healthcare 25.89%
2 Technology 24.22%
3 Financials 21.01%
4 Communication Services 9.7%
5 Consumer Discretionary 6.11%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WCG
51
DELISTED
Wellcare Health Plans, Inc.
WCG
$27M 0.55%
313,200
+194,129
+163% +$17M
CRM icon
52
Salesforce
CRM
$144B
$26.7M 0.54%
384,352
+51,026
+15% +$3.62M
Y
53
DELISTED
Alleghany Corp
Y
$26.5M 0.54%
56,700
MCK icon
54
McKesson
MCK
$100B
$26.5M 0.54%
143,421
+138,421
+2,768% +$29.3M
DVAX
55
DELISTED
Dynavax Technologies
DVAX
$26.5M 0.54%
1,080,944
-38,589
-3% -$1.09M
RHT
56
DELISTED
Red Hat Inc
RHT
$26.4M 0.53%
367,095
+70,477
+24% +$5.3M
BABA icon
57
Alibaba
BABA
$274B
$26.3M 0.53%
446,865
+104,385
+30% +$7.59M
IQV icon
58
IQVIA
IQV
$35.3B
$26.3M 0.53%
377,653
+56,817
+18% +$4.25M
ENDP
59
DELISTED
Endo International plc
ENDP
$25.7M 0.52%
370,499
+41,999
+13% +$3.36M
SPLK
60
DELISTED
Splunk Inc
SPLK
$25.5M 0.52%
460,823
+102,303
+29% +$6.68M
FTRPR
61
DELISTED
Frontier Communications Corporation 11.125% Series A Mandatory Convertible Preferred Stock
FTRPR
$25.4M 0.51%
271,000
+29,500
+12% +$2.96M
TRIP icon
62
TripAdvisor
TRIP
$1.67B
$25.3M 0.51%
401,604
+85,927
+27% +$6.5M
NMBL
63
DELISTED
Nimble Storage, Inc.
NMBL
$25.2M 0.51%
1,043,900
+382,868
+58% +$9.99M
PFPT
64
DELISTED
Proofpoint, Inc.
PFPT
$24.5M 0.5%
406,277
+94,914
+30% +$5.9M
STJ
65
DELISTED
St Jude Medical
STJ
$24.3M 0.49%
+385,000
New +$27.5M
BRK.B icon
66
Berkshire Hathaway Class B
BRK.B
$1.07T
$24M 0.49%
183,963
+1,963
+1% +$269K
HCA icon
67
HCA Healthcare
HCA
$86B
$24M 0.49%
310,071
-125,929
-29% -$11.2M
AMSG
68
DELISTED
Amsurg Corp
AMSG
$23.8M 0.48%
306,263
-6,200
-2% -$478K
N
69
DELISTED
Netsuite Inc
N
$23.5M 0.48%
280,135
+48,900
+21% +$4.49M
VMW
70
DELISTED
VMware, Inc
VMW
$23.4M 0.47%
296,672
+60,033
+25% +$4.99M
ACHC icon
71
Acadia Healthcare
ACHC
$2.99B
$23.2M 0.47%
350,500
PTLA
72
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
$22.7M 0.46%
532,987
+15,361
+3% +$741K
ZEN
73
DELISTED
ZENDESK INC
ZEN
$22.6M 0.46%
1,147,868
+384,468
+50% +$8.08M
EVHC
74
DELISTED
Envision Healthcare Holdings Inc
EVHC
$22.3M 0.45%
202,738
-23,213
-10% -$2.87M
EBAY icon
75
eBay
EBAY
$50.1B
$21.9M 0.44%
896,894
-425,740
-32% -$11.4M

Similar funds

Polar Capital's Q3 2015 Portfolio in Review

As of Q3 2015, Polar Capital held 310 positions worth $4.94B, down 4.9% from $5.2B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Polar Capital deployed $155M of net new capital in Q3 2015, opening 46 new positions and adding to 109 existing holdings. Its largest new stake was Allergan plc: 171,100 shares worth $46.5M.

By sector, the portfolio is most concentrated in Healthcare at 26% of assets, up from 24% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was Thermo Fisher Scientific, an estimated $45M trimmed.

  • Polar Capital's largest Q3 2015 buy was Allergan plc: 171,100 shares worth $46.5M.
  • Polar Capital added most to UnitedHealth in Q3 2015, an estimated $48.5M increase.
  • Polar Capital's biggest Q3 2015 reduction was Thermo Fisher Scientific, cutting an estimated $45M.
  • Polar Capital fully exited Time Warner Inc in Q3 2015, selling an estimated $55.2M.
  • Polar Capital's ten largest holdings make up 23% of its $4.94B portfolio in Q3 2015.
  • Polar Capital opened 46 new positions and closed 39 in Q3 2015.
  • Polar Capital's portfolio value fell 4.9% quarter-over-quarter to $4.94B.

Based on Polar Capital's 13F filing for Q3 2015, filed 16 Nov 2015.